thought to lead to accelerated atherogenesis but the underlying mechanisms are still poorly understood.
Materials and methods
cetic acid (1.0 mg/ml ). The separated blood cells were used for determining ApoE genotype. All patients from a single dialysis centre were invited to participate in the present study. The baseline examination was conducted between May 1994 and June 1994. Venous Amplification of genomic DNA by PCR blood was taken from 157 ESRD patients ( HD, 119 patients; CAPD, 38 patients) aged between 23 and 83 years (mean Leucocyte DNA was extracted from the whole blood by using the method of Higuchi [15] . We PCR-amplified the age 56.5±13.7 years) and from 84 healthy controls aged between 21 and 82 years (mean age 58.6±12.5 years). desired DNA fragment by utilizing a DNA thermal cycler (MJ ) along with an upstream primer: Informed consent was obtained from each of the studied subjects. The causes of ESRD were chronic glomerulo-5∞-TCCAAGGAGCTGCAGGCGGCGCA-3∞ and a downnephritis in 85 patients (54%), diabetic nephropathy in 30 stream primer: ( 19%), chronic pyelonephritis in 18 (11%), polycystic kidney 5∞-ACAGAATTCGCCCCGCCTGGTACACTG-3∞ disease in three ( 2%), and other diseases in 11 ( 7%). The cause was unknown in 10 (7%) patients. The haemodialysis Each amplification reaction contained 250 ng of genomic DNA, 20 pmol of each primer, 10% dimethylsulfoxide, patients received thrice-weekly treatments to maintain a minimum Kt/V urea index of 1.2 per session. On the other 220 mM of each dNTP, and 0.3 ml of Dynazyme DNA polymerase ( 2 units/ml ) in a final volume of 25 ml. Thermal hand, the CAPD patients received 4-5 2-l bags to achieve a Kt/V urea index of 1.9 per week.
profile of the PCR was denaturation for 60 s at 95°C, annealing for 60 s at 55°C, and extension for 2 min at 72°C. The follow-up study was conducted between April 1996 and June 1996. The follow-up period for the subjects was 2 A total of 30 cycles was performed. The PCR products were digested with cfoI. The DNA fragments were separated by years. Among the 157 uraemic patients who participated in the baseline study, 14 died during follow-up. Causes of death electrophoresis on an ethidium bromide-containing 4% agarose gel. DNA fragments were visualized by UV transand cardiovascular events were recorded. illumination ( Fig. 1 ) . ApoE genotypes for the case and control groups were determined in a blinded fashion by
Diagnosis of previous and new ischaemic stroke
scoring for a unique combination of fragment sizes as described by Hixon and Vernier [ 16 ] . All medical records of subjects with symptoms suggestive of ischaemic stroke before the baseline examination and during follow-up were reviewed by one of the authors. The verified Statistical analysis ischaemic stroke was defined as a clinical syndrome consisting of neurological deficits persisting over 24 h and observed by Statistical analysis were performed using the SPSS/PC proat least one neurologist, in the absence of other diseases gram. Data are given as mean±SEM or percentages. For accounting for the symptoms. Patients with subarachnoid comparisons of the parameters between the control and the haemorrhage and haemorrhagic strokes were excluded from patients' groups as shown in Table 1 , the non-parametric the study. A computed tomograph was performed in all cases Mann-Whitney two-sample test for unpaired data was perbut was required only as supportive evidence for the diagnosis formed. x2 test was used to assess the diÂerences between of ischaemic stroke. In the following analyses, non-fatal and groups when appropriate. The stepwise logistic regression fatal strokes were combined because of a limited number of was used to describe the strength of the prognostic factors stroke end-points. If a subject had more than one stroke selected which included: hypertension, ApoA1 level, ApoB during the follow-up period, only one stroke event was level, ApoE genotype, diabetes mellitus, age, and sex. included in the statistical analyses.
Results

Risk factors evaluation
The atherosclerotic risk factors such as hypertension and The observed allele frequencies of the ApoE gene in diabetes mellitus were evaluated based on multiple laboratory normal controls were 6% for e2, 82% for e3, and 12% measurements. Patients were classified as hypertensive for e4, whereas those for uraemic patients were 5.7% when the blood pressure was >95 mmHg diastolic and/or for e2, 86.3% for e3, and 8% for e4, respectively. As in >160 mmHg systolic and/or treated with antihypertensive medications. Diagnosis of diabetes mellitus were considered if the subjects were taking oral hypoglycaemic agents or measured after phosphotungstate precipitation and centrifugation of LDL at the isoelectric point of LDL ( pL=7.5). LDL-containing cholesterol was all measured directly.
aP<0.001, significant diÂerence between uraemic control and healthy subjects by x2 test.
Whole blood from control and studied patients (in a fasted that only ApoE genotype (e4) was significant (P<0.05) and may serve as an independent predictor of the occurrence of the ischaemic cerebrovascular disease in aStatistically significant. dialysis patients ( Table 3) .
in the other populations [6, [17] [18] [19] [20] [21] . Studies involving
Discussion
Caucasians have so far shown average relative allele frequencies of 0.77-0.78 for e3, 0.08 for e2, and 0.14 for e4 [6, [18] [19] [20] . In some of these ethnic groups such The distribution of the diÂerent genotypes in our control group were similar to those previously reported as Finnish people who are known to have increased incidence of atherosclerosis, the relative allele frequen-of an ApoE gene into ApoE deficient mice leads to cies were found to be 0.73 for e3, 0.04 for e2 and 0.23 normalization of plasma lipid levels, protection from for e4, respectively. Although the e4 allele frequency diet-induced atherosclerosis, and regression of prein our uraemic population was found to be 0.08 which existing plaques. The results of these studies suggest a was lower than the subjects in the normal control direct eÂect of ApoE on lipoprotein metabolism and group viz. e4 0.12, the diÂerence did not reach statistical atherosclerosis on at least two levels. First, it inhibits significance. the formation of atherosclerotic plaques via its reduInconsistency about the risk eÂect of ApoE poly-cing eÂect of plasma remnant lipoprotein levels. morphism on coronary heart disease (CHD) had been Secondly, the regression of plaques is enhanced via its reported for more than a decade [22] [23] [24] [25] [26] . Context-stimulatory eÂect on cellular cholesterol eÄux. dependency of ApoE polymorphism-associated eÂects In contrast to most previous studies [6, [34] [35] , the has also been reported recently in long-term prospect-total cholesterol and LDL cholesterol in our uraemic ive studies [27] [28] [29] . Ethnic origin, gender, and life style subjects with ApoE e4 allele were significantly lower including diet have been recognized as factors which than in those without. From previous experimental can influence a specific ApoE phenotype. In addition, studies, it was found that E4-containing lipoproteins several recent pilot studies [13] [14] have demonstrated such as VLDL and chylomicron remnants are catabolthat ApoE e4 is associated with ischaemic cerebrovas-ized at a higher rate, with an eÃcient delivery of cular disease in the general population. In two earlier cholesterol and triglycerides to the liver [36] [37] [38] . This reports, there was higher prevalence of ApoE e4 poly-in turn leads to a down-regulation of LDL receptors morphism in ICVD patients than in control subjects. and a higher plasma LDL concentration. In addition, However, in the study conducted by Coudere et al. diÂerences in hepatic cholesterol synthesis could also [14 ] ApoE e2 allele was found to be a risk factor for aÂect the observed cholesterol level [39] . As the hepatic cerebrovascular disease. The discrepancies between cholesterol homeostasis is directly related to the indithese studies were most probably due to diÂerences in vidual's nutritional status, and the nutritional status patient selection criteria. In our uraemic population, of uraemic subjects are generally poorer, this probably we found that the incidence and cumulative occurrence may negate the eÂect of ApoE apolipoproteins on of stroke increased significantly in those with the ApoE plasma cholesterol levels. In subjects with e4 allele, e4 allele. This preliminary observation probably sugthere is also a higher rate of ApoE-mediated conversion gests that e4 allele could be a predisposing genetic of VLDL remnants to LDL. However, in uraemic marker for ischaemic cerebrovascular disease in these patients, due to a reduced activity of lipoprotein lipase, uraemic patients. such conversion could be defective resulting in an Cardiovascular diseases account for >50% of overall mortality and morbidity in uraemic patients, according accumulation of VLDL remnants. In fact, our present to the EDTA Registry [30 ] . What has become clear is study observed higher triglyceride levels in uraemic that these uraemic patients have a high incidence and subjects with Apo e4 allele although the results did not prevalence of atherosclerotic diseases which may be reach a significant level. related to numerous traditional atherogenic risk factors
Results from the present study also demonstrated such as hypertension, diabetes mellitus, abnormalities that ApoA1 concentrations were significantly lower in of calcium and phosphate metabolism, as well as subjects with ApoE e4 than those without e4. Such an uraemic dyslipidemia. However, these classic factors association between ApoA1 and stroke has been do not explain all cerebrovascular events in uraemic described recently by several authors [15, [29] [30] . These patients, and new risk factors have to be sought. In authors found that a low ApoA1 concentration recent years, apolipoproteins such as ApoA1 and ApoE increases the risk for cerebral and lacunar infarct. The have been one of the main targets of interest. In this protective eÂect of ApoA1 may be related to its action study a stepwise logistic regression analysis was per-against the accumulation of platelet thrombi at sites formed to remove possible bias due to unmatched of vascular damage. The hypothesis that ApoE polyfactors and to appreciate the influence of covariables. morphism and/or ApoA1 could be a marker of atheroIn addition to the matching variables of age and sex, sclerosis suggests that apolipoproteins may be more each of the variables strongly associated with the important in atherogenesis than the lipid component. presence of ischaemic cerebrovascular disease was Since genetic factors may influence the concentration included in the model. The results clearly show that in of the protein moiety, more than environmental facthese uraemic subjects, ApoE e4 was independently tors, genetic factors may have significant role in deterassociated with ICVD.
mining the predisposition of the subjects to stroke. On The mechanisms by which ApoE influences vascular the basis of our findings, we can speculate that it is atherogenesis are far from being understood. Over the very likely that the ApoE e4 allele may form an past few years, the role that ApoE plays in lipoprotein increased risk for ICVD in uraemic subjects. metabolism and atherogenesis has been extensively
In conclusion, our study has demonstrated that at studied using genetically modified mice. Some authors least for Chinese uraemic patients, carrying ApoE e4 found that severe dyslipidaemia and atherosclerotic allele is a risk factor for ischaemic cerebrovascular lesions develop in ApoE-deficient mice [6, 31] . Others [32] [33] have also demonstrated that the introduction disease.
